Emerald Health Pharmaceuticals will Present at the International Cannabinoid-Derived Pharmaceuticals Summit

SAN DIEGO, CA, Dec. 04, 2018 (GLOBE NEWSWIRE) — Emerald Health Pharmaceuticals Inc. (EHP), a clinical-stage company developing medicines based on cannabinoid science, today announced that Dr. Jim DeMesa, CEO of EHP will be featured as a speaker at the International Cannabinoid-Derived Pharmaceuticals Summit to be held on December 11-12, 2018 at The Revere Hotel in Boston, MA. Details of the presentation are as follows:

by

Leave a Reply